Sanotide® contains Actronide Acetate, a lyophilized medication used for intravenous injection. This drug serves as a specialized anti-hemorrhagic agent to control and prevent bleeding in patients with coagulation disorders, particularly Hemophilia A patients who have developed Factor VIII inhibitors. By activating alternative therapeutic pathways, Sanotide helps manage bleeding in acute conditions. It must be administered exclusively in a hospital setting under the supervision of a hematologist or blood specialist.
Actronide Acetate is a bypassing agent that helps control bleeding by activating the coagulation pathway independently of Factor VIII. The drug effectively bypasses the impaired coagulation pathway, enabling effective clotting in patients with Factor VIII inhibitors. Its effects appear rapidly, making it a critical component in managing acute hemorrhages or preparing for surgical interventions.
Store in the refrigerator (2°C to 8°C).
Do not freeze the medication.
Keep in the original box to protect from light.
Inspect the vial’s integrity before reconstitution.
Reconstitution must only be performed by authorized healthcare personnel.
Prohibited for use without a prescription and specialist supervision. Use with extreme caution in patients with:
History of thrombosis.
Cardiovascular diseases.
Concurrent use of anticoagulants.
Use during pregnancy and lactation only upon a physician’s diagnosis.
Any allergic reactions such as hives, shortness of breath, or swelling must be reported immediately.
Contraindications:
Known hypersensitivity to Actronide Acetate or any excipients.
Presence of active thrombosis or a recent history of DVT/PE.
Administration outside of equipped medical facilities.
Common: Fever, headache, pain at the injection site, and slight increase in blood pressure.
Less Common but Important: Risk of thrombosis, allergic reactions, hives or skin lesions, and changes in coagulation test results.
A physician must be informed immediately if any abnormal symptoms occur.
Sanotide is supplied in standard, durable hospital boxes containing one 30 mg lyophilized vial of Actronide Acetate. The packaging features a distinct blue-white color scheme for easy identification. Comprehensive information, including product name, dosage, administration method, expiration date, batch number, and storage conditions, is printed on the box. The packaging structure protects the vial from light, impact, and contamination, ensuring complete safety during handling within medical centers.
Reviews
There are no reviews yet.